Is CMRAW stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Comera Life Sciences 10 years ago, but if you had invested on Friday 20th of May 2022 when the price was $0.500, you would have made a loss of $-0.499 per share or -99.84%
No, the average daily trading liquidity for Comera Life Sciences is $564 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Comera Life Sciences has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Comera Life Sciences to be medium [0.7 out of 1]